Human medicines European public assessment report (EPAR): Bopediat, furosemide, Status: Opinion

Back to news list

Source: EMA New Medicines

Original: https://www.ema.europa.eu/en/medicines/human/EPAR/bopediat...

Published: Fri, 27 Mar 2026 12:41:00 +0100

A European Public Assessment Report (EPAR) for Bopediat, which contains furosemide, is available. The document has the status "Opinion". The EPAR provides information on the evaluation of the medicine by the European Medicines Agency (EMA). Furosemide is a drug used as a diuretic. Bopediat is a medicine intended for humans. The EPAR is a publicly available document. The opinion indicates that the evaluation of the drug has been completed.